NSB BPO Solutions Fund Raise of ₹64.13 Cr

NSB BPO Solutions Other Announcement

NSB BPO Solutions filed its quarterly investor grievance report under Reg 13(3) LODR for Q1 FY27. All complaint categories—pending, received, resolved, and unresolved—are NIL.

NSB BPO Solutions Annual General Meeting

NSB BPO Solutions Ltd shareholders approved eight resolutions at their Annual General Meeting. Key outcomes include increasing borrowing limits to ₹150 Crore and approving related party transactions.

Value

₹150.0 Cr

NSB BPO Solutions Annual General Meeting

NSB BPO Solutions Ltd held its 21st Annual General Meeting on 30th September, 2026. The meeting transacted ordinary and special business, including board appointments and borrowing authorizations.

NSB BPO Solutions Management Change

NSB BPO Solutions' shareholders approved the appointment of Dr. Abhiraj Singh Rana as an Independent Director during the 21st Annual General Meeting.

NSB BPO Solutions Annual Report

NSB BPO Solutions Ltd has submitted its 21st Annual Report for the financial year 2025-26, including the notice for the upcoming Annual General Meeting.

NSB BPO Solutions Annual General Meeting

NSB BPO Solutions Limited has issued the notice for its 21st Annual General Meeting scheduled for September 30, 2026.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.